Abstract
Heat shock protein (HSP) 60 functions as a key signal to the immune system: its expression is up-regulated under inflammation and HSP60-reactive T and B cells were observed in almost all inflammatory diseases. Moreover, HSP60 induces pro-inflammatory phenotype in innate immune cells via Toll-like receptors (TLRs). Accordingly, HSP60 has been considered a pro-inflammatory “danger signal”. However, HSP60 have immunoregulatory potential and could arrest inflammatory damage. In this chapter we discuss recent findings indicating that T and B cells may directly respond to HSP60 via TLR-2 and TLR4 respectively. HSP60 inhibits T-cell chemotaxis, shift the cytokine secretion balance towards a Th2 phenotype, and activates the suppression ability of Treg. B cells responding to HSP60 secreted also high levels of IL-10. Then, these innate effects of HSP60 on adaptive immune system lead to resolution of inflammation. Thus, HSP60, which is up-regulated by stress and inflammation, can innately resolve it
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abulafia-Lapid R, Elias D, Raz I, Keren-Zur Y, Atlan H and Cohen IR. T cell proliferative responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides. J Autoimmun 12: 121–129., 1999.
Babu UM and Zeiger AR. Soluble peptidoglycan from Staphylococcus aureus is a murine B-lymphocyte mitogen. Infect Immun. 42: 1013–1016., 1983.
Chambers CA and Allison JP. Co-stimulation in T cell responses. Curr Opin Immunol 9: 396–404., 1997.
Cohen IR. Autoimmunity to chaperonins in the pathogenesis of arthritis and diabetes. Annu Rev Immunol 9: 567–589., 1991.
Cohen IR. Discrimination and dialogue in the immune system. Semin Immunol 12: 215–219; discussion 257–344., 2000a.
Cohen IR. Tending Adam’s Garden: Evolving the Cognitive Immune Self. London: Academic press, 2000b.
Cohen-Sfady M, Nussbaum G, Pevsner-Fischer M, Mor F, Carmi P, Zanin-Zhorov A, Lider O and Cohen IR. Heat shock protein 60 activates B cells via the TLR4-MyD88 pathway. J Immunol. 175: 3594–3602., 2005.
Delves PJ and Roitt IM. The immune system. First of two parts. N Engl J Med. 343: 37–49., 2000.
Direskeneli H, Eksioglu-Demiralp E, Yavuz S, Ergun T, Shinnick T, Lehner T and Akoglu T. T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behcet’s disease. J Rheumatol 27: 708–713., 2000.
Dustin ML, Allen PM and Shaw AS. Environmental control of immunological synapse formation and duration. Trends Immunol 22: 192–194., 2001.
Elias D, Markovits D, Reshef T, van der Zee R and Cohen IR. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc Natl Acad Sci U S A 87: 1576–1580., 1990.
Elias D, Meilin A, Ablamunits V, Birk OS, Carmi P, Konen-Waisman S and Cohen IR. Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens. Diabetes 46: 758–764., 1997.
Ferm MT, Soderstrom K, Jindal S, Gronberg A, Ivanyi J, Young R and Kiessling R. Induction of human hsp60 expression in monocytic cell lines. Int Immunol 4: 305–311., 1992.
Fischer HP, Sharrock CE and Panayi GS. High frequency of cord blood lymphocytes against mycobacterial 65-kDa heat-shock protein. Eur J Immunol 22: 1667–1669., 1992.
Flohe SB, Bruggemann J, Lendemans S, Nikulina M, Meierhoff G, Flohe S and Kolb H. Human heat shock protein 60 induces maturation of dendritic cells versus a Th1-promoting phenotype. J Immunol 170: 2340–2348., 2003.
Gao B and Tsan MF. Recombinant human heat shock protein 60 does not induce the release of tumor necrosis factor alpha from murine macrophages. J Biol Chem 278: 22523–22529. Epub 22003 Apr 22509., 2003.
Han SB, Park SK, Ahn HJ, Yoon YD, Kim YH, Lee JJ, Lee KH, Moon JS, Kim HC and Kim HM. Characterization of B cell membrane receptors of polysaccharide isolated from the root of Acanthopanax koreanum. Int Immunopharmacol. 3: 683–691., 2003.
Hu W, Hasan A, Wilson A, Stanford MR, Li-Yang Y, Todryk S, Whiston R, Shinnick T, Mizushima Y, van der Zee R and Lehner T. Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336–351. Eur J Immunol 28: 2444–2455., 1998.
Jindal S, Dudani AK, Singh B, Harley CB and Gupta RS. Primary structure of a human mitochondrial protein homologous to the bacterial and plant chaperonins and to the 65-kilodalton mycobacterial antigen. Mol Cell Biol 9: 2279–2283., 1989.
Kol A, Lichtman AH, Finberg RW, Libby P and Kurt-Jones EA. Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J Immunol 164: 13–17., 2000.
Komai-Koma M, Jones L, Ogg GS, Xu D and Liew FY. TLR2 is expressed on activated T cells as a costimulatory receptor. Proc Natl Acad Sci U S A 101: 3029–3034. Epub 2004 Feb 3023., 2004.
Lanzavecchia A and Sallusto F. Progressive differentiation and selection of the fittest in the immune response. Nat Rev Immunol 2: 982–987., 2002.
Lindquist S and Craig EA. The heat-shock proteins. Annu Rev Genet 22: 631–677., 1988.
Liu H, Komai-Koma M, Xu D and Liew FY. Toll-like receptor 2 signaling modulates the functions of CD4+CD25+ regulatory T cells. Proc Natl Acad Sci U S A 21: 21, 2006.
Medzhitov R and Janeway CA, Jr. How does the immune system distinguish self from nonself? Semin Immunol 12: 185–188; discussion 257–344., 2000.
Ohashi K, Burkart V, Flohe S and Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164: 558–561., 2000.
Peng G, Guo Z, Kiniwa Y, Voo KS, Peng W, Fu T, Wang DY, Li Y, Wang HY and Wang RF. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science. 309: 1380–1384., 2005.
Quintana FJ, Carmi P, Mor F and Cohen IR. Inhibition of adjuvant arthritis by a DNA vaccine encoding human heat shock protein 60. J Immunol 169: 3422–3428., 2002.
Raz I, Elias D, Avron A, Tamir M, Metzger M and Cohen IR. Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. Lancet 358: 1749–1753., 2001.
Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, Nomura T, Toda M and Takahashi T. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 182: 18–32., 2001.
Shevach EM. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2: 389–400., 2002.
Soriano SF, Hernanz-Falcon P, Rodriguez-Frade JM, De Ana AM, Garzon R, Carvalho-Pinto C, Vila-Coro AJ, Zaballos A, Balomenos D, Martinez AC and Mellado M. Functional inactivation of CXC chemokine receptor 4-mediated responses through SOCS3 up-regulation. J Exp Med 196: 311–321., 2002.
Sutmuller RP, den Brok MH, Kramer M, Bennink EJ, Toonen LW, Kullberg BJ, Joosten LA, Akira S, Netea MG and Adema GJ. Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest. 116: 485–494. Epub 2006 Jan 2019., 2006.
Tsan MF and Gao B. Cytokine function of heat shock proteins. Am J Physiol Cell Physiol 286: C739–744., 2004.
Tzehoval E, De Baetselier P, Ron Y, Tartakovsky B, Feldman M and Segal S. Splenic B cells function as immunogenic antigen-presenting cells for the induction of effector T cells. Eur J Immunol. 13: 89–94., 1983.
Vabulas RM, Ahmad-Nejad P, da Costa C, Miethke T, Kirschning CJ, Hacker H and Wagner H. Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem 276: 31332–31339. Epub 32001 Jun 31311., 2001.
van Eden W, Thole JE, van der Zee R, Noordzij A, van Embden JD, Hensen EJ and Cohen IR. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 331: 171–173., 1988.
Wick G. Atherosclerosis–an autoimmune disease due to an immune reaction against heat-shock protein 60. Herz 25: 87–90., 2000.
Xu D, Komai-Koma M and Liew FY. Expression and function of Toll-like receptor on T cells. Cell Immunol. 233: 85–89., 2005.
Yokota SI, Hirata D, Minota S, Higashiyama T, Kurimoto M, Yanagi H, Yura T and Kubota H. Autoanti- bodies against chaperonin CCT in human sera with rheumatic autoimmune diseases: comparison with antibodies against other Hsp60 family proteins. Cell Stress Chaperones 5: 337–346., 2000.
Young DB. Heat-shock proteins: immunity and autoimmunity. Curr Opin Immunol 4: 396–400., 1992.
Zanin-Zhorov A, Bruck R, Tal G, Oren S, Aeed H, Hershkoviz R, Cohen IR and Lider O. Heat shock protein 60 inhibits Th1-mediated hepatitis model via innate regulation of Th1/Th2 transcription factors and cytokines. J Immunol 174: 3227–3236., 2005b.
Zanin-Zhorov A, Cahalon L, Tal G, Margalit R, Lider O and Cohen I. Heat Shock Protein 60 Enhances CD4+CD25+ Regulatory T-Cell Function via Innate TLR2 Signaling. Journal of Clinical Investigation in press, 2006.
Zanin-Zhorov A, Nussbaum G, Franitza S, Cohen IR and Lider O. T cells respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptors. Faseb J 17: 1567–1569. Epub 2003 Jun 1517., 2003.
Zanin-Zhorov A, Tal G, Shivtiel S, Cohen M, Lapidot T, Nussbaum G, Margalit R, Cohen IR and Lider O. Heat Shock Protein 60 Activates Cytokine-associated Negative Regulator SOCS3 in T cells: Effects on Signaling, Chemotaxis, and Inflammation. J Immunol 175: 276–285, 2005a.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer
About this chapter
Cite this chapter
Zanin-Zhorov, A., Cohen, I.R. (2007). HSP60: A Pleiotropic Immune Signal. In: Asea, A.A., Maio, A.D. (eds) Heat Shock Proteins: Potent Mediators of Inflammation and Immunity. Heat Shock Proteins, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-5585-0_16
Download citation
DOI: https://doi.org/10.1007/978-1-4020-5585-0_16
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-5584-3
Online ISBN: 978-1-4020-5585-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)